Behavioral Dynamics, Genomic Insights, and Social Drivers of SARS-CoV-2 Waves and Variants in Cali, Colombia (2020-2023).

Publication date: May 30, 2025

In Cali, Colombia, 405,689 COVID-19 cases were reported until March 2023, with 2463 complete genome sequences available for analysis. SARS-CoV-2 genomic data from Cali were analyzed to determine the prevalence of variants as well as the mutation frequencies. This study identified Nextstrain clades, Pango lineages, and specific mutations in key viral proteins. A total of 23 Nextstrain clades and 118 Pango lineages were detected, including variants of interest (Lambda, Mu) and variants of concern (Alpha, Gamma, Delta, Omicron). Analysis identified 2424 missense mutations, with notable frequencies in NSP3 (465), S (367), NSP2 (205), N (180), ORF3a (144), NSP12b (113), and NSP13 (108). The study also observed a high prevalence of simultaneous transmission of multiple variants. The COVID-19 epidemic waves in Cali were shaped more by social and economic dynamics than by the emergence of specific SARS-CoV-2 variants. These findings highlight the importance of context-specific public health interventions to mitigate future outbreaks effectively.

Open Access PDF

Concepts Keywords
Colombia Colombia
Genomic COVID-19
Viruses epidemic waves
Genome, Viral
genomic surveillance
Genomics
Humans
Mutation
mutations
Phylogeny
SARS-CoV-2
social transmission

Semantics

Type Source Name
disease MESH COVID-19
disease MESH mutation frequencies
disease IDO country
disease IDO protein
drug DRUGBANK BIA
disease IDO pathogen
disease IDO nucleic acid
disease IDO assay
disease MESH Influenza
disease MESH Infection
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
drug DRUGBANK Cysteamine
disease MESH infectious diseases
disease MESH unemployment
disease MESH violence
disease IDO virulence
disease IDO host
disease MESH Respiratory Diseases
disease MESH Viral Diseases
drug DRUGBANK Aminosalicylic Acid
disease IDO algorithm

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *